Literature DB >> 31139984

Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma.

S O'Brien1, N Bhutiani1, M E Egger1, A N Brown1, K H Weaver1, D Kline1, L R Kelly2, C R Scoggins1, R C G Martin1, G C Vitale3.   

Abstract

BACKGROUND: In patients with cholangiocarcinoma (CC), management of biliary obstruction commonly involves either up-front percutaneous transhepatic biliary drainage (PTBD) or initial endoscopic retrograde cholangiopancreatography (ERCP) with stent placement. The objective of the study was to compare the efficacy and of initial ERCP with stent placement with efficacy of initial PTBD in management of biliary obstruction in CC.
METHODS: A single-center database of patients with unresectable CC treated between 2006 and 2017 was queried for patients with biliary obstruction who underwent either PTBD or ERCP. Groups were compared with respect to patient, tumor, procedure, and outcome variables.
RESULTS: Of 87 patients with unresectable CC and biliary obstruction, 69 (79%) underwent initial ERCP while 18 (21%) underwent initial PTBD. Groups did not differ significantly with respect to age, gender, or tumor location. Initial procedure success did not differ between the groups (94% ERCP vs 89% PTBD, p = 0.339). Total number of procedures did not differ significantly between the two groups (ERCP median = 2 vs. PTC median = 2.5, p = 0.83). 21% of patients required ERCP after PTBD compared to 25% of patients requiring PTBD after ERCP (p = 1.00). Procedure success rate (97% ERCP vs. 93% PTBD, p = 0.27) and rates of cholangitis (22% ERCP vs. 17% PTBD, p = 0.58) were similar between the groups. Number of hospitalizations since initial intervention did not differ significantly between the two groups (ERCP median = 1 vs. PTC median = 3.5, p = 0.052).
CONCLUSIONS: In patients with CC and biliary obstruction, initial ERCP with stent placement and initial PTBD both represent safe and effective methods of biliary decompression. Initial ERCP and stenting should be considered for relief of biliary obstruction in such patients in centers with advanced endoscopic capabilities.

Entities:  

Keywords:  Cholangiocarcinoma; ERCP; Percutaneous transhepatic biliary drainage

Mesh:

Year:  2019        PMID: 31139984     DOI: 10.1007/s00464-019-06871-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  19 in total

1.  Complications of diagnostic and therapeutic ERCP: a prospective multicenter study.

Authors:  E Masci; G Toti; A Mariani; S Curioni; A Lomazzi; M Dinelli; G Minoli; C Crosta; U Comin; A Fertitta; A Prada; G R Passoni; P A Testoni
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

2.  Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial.

Authors:  Apichat Sangchan; Worrarat Kongkasame; Ake Pugkhem; Kriangsak Jenwitheesuk; Pisaln Mairiang
Journal:  Gastrointest Endosc       Date:  2012-05-15       Impact factor: 9.427

3.  Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival.

Authors:  Xu-Feng Zhang; Eliza W Beal; Katiuscha Merath; Cecilia G Ethun; Ahmed Salem; Sharon M Weber; Thuy Tran; George Poultsides; Andre Y Son; Ioannis Hatzaras; Linda Jin; Ryan C Fields; Matthew Weiss; Charles Scoggins; Robert C G Martin; Chelsea A Isom; Kamron Idrees; Harveshp D Mogal; Perry Shen; Shishir K Maithel; Carl R Schmidt; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2017-12-04       Impact factor: 3.454

Review 4.  Perioperative Management of Hilar Cholangiocarcinoma.

Authors:  Katherine E Poruk; Timothy M Pawlik; Matthew J Weiss
Journal:  J Gastrointest Surg       Date:  2015-05-29       Impact factor: 3.452

5.  Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma.

Authors:  Satoshi Hirano; Eiichi Tanaka; Takahiro Tsuchikawa; Joe Matsumoto; Hiroshi Kawakami; Toru Nakamura; Yo Kurashima; Yuma Ebihara; Toshiaki Shichinohe
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-01-27       Impact factor: 7.027

6.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

Review 7.  A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice.

Authors:  Miguel E Sewnath; Thomas M Karsten; Martin H Prins; Erik J A Rauws; Huug Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

8.  Result of endoscopic biliary drainage in hilar cholangiocarcinoma.

Authors:  Rungsun Rerknimitr; Nusont Kladcharoen; Varocha Mahachai; Pinit Kullavanijaya
Journal:  J Clin Gastroenterol       Date:  2004-07       Impact factor: 3.062

9.  Chemotherapy for cholangiocarcinoma: An update.

Authors:  Natalia Ramírez-Merino; Santiago Ponce Aix; Hernán Cortés-Funes
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

Review 10.  Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review.

Authors:  Harsha Moole; Sirish Dharmapuri; Abhiram Duvvuri; Sowmya Dharmapuri; Raghuveer Boddireddy; Vishnu Moole; Prathyusha Yedama; Naveen Bondalapati; Achuta Uppu; Charan Yerasi
Journal:  Can J Gastroenterol Hepatol       Date:  2016-08-25
View more
  2 in total

1.  The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines.

Authors:  Zhi Ven Fong; Sarah A Brownlee; Motaz Qadan; Kenneth K Tanabe
Journal:  Ann Surg Oncol       Date:  2021-03-01       Impact factor: 5.344

2.  Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy.

Authors:  Maria A Gonzalez-Carmona; Christian Möhring; Robert Mahn; Taotao Zhou; Alexandra Bartels; Farsaneh Sadeghlar; Maximilian Bolch; Annabelle Vogt; Dominik J Kaczmarek; Dominik J Heling; Leona Dold; Jacob Nattermann; Vittorio Branchi; Hanno Matthaei; Steffen Manekeller; Jörg C Kalff; Christian P Strassburg; Raphael U Mohr; Tobias J Weismüller
Journal:  Sci Rep       Date:  2022-01-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.